Melphalan Hydrochloride (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Melphalan Hydrochloride drug offered from Par Pharmaceutical, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Melphalan Hydrochloride
SUBSTANCE NAME: MELPHALAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-08-26
END MARKETING DATE: 0000-00-00


Melphalan Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMelphalan Hydrochloride from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/10mL)
START MARKETING DATE: 2016-08-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-149_67fde26e-6c43-4a79-bd9f-ec383f964cf4
PRODUCT NDC: 42023-149
APPLICATION NUMBER: ANDA204773

Other MELPHALAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Melphalan
Apo-Pharma USA, IncALKERAN
Par Pharmaceutical, Inc.Melphalan Hydrochloride